| 2026 | | Comprehensive Multi-Omics Characterization of CYP2R1 as a Diagnostic and Functional Biomarker in Hepatocellular Carcinoma | 김순선, 은정우, 정재연 |
| 2026 | | Correspondence to letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
Clinical and molecular hepatology, 32(1). : e103-e105, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Correspondence to editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
Clinical and molecular hepatology, 32(1). : e72-e74, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Uncovering the MET-TRIB3-FOXO1 axis: A novel target in MET-driven hepatocellular carcinoma: Editorial on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
Clinical and molecular hepatology, 32(1). : 436-438, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Reply to correspondence 2 on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
Clinical and molecular hepatology, 32(1). : e121-e124, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Bacteroides eggerthii ameliorates metabolic dysfunctionassociated steatotic liver disease through host–microbe signaling and highlights 2-hydroxyisocaproate as a potential effector
Clinical and molecular hepatology, 32(1). : 239-257, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Enhanced pathogen detection and gut microbiome alterations in pyogenic liver abscess: insights from next-generation sequencing
Gut pathogens, 18(1). : 16-16, 2026 | 김순선 |
| 2026 | | Transformer-Based Risk Estimation of HCC in Patients with Chronic Hepatitis B
Lecture notes in computer science, 16164 LNCS. : 221-233, 2026 | 김순선, 정재연 |
| 2026 | | Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
World journal of gastroenterology, 32(3). : 114176-114176, 2026 | 김순선 |
| 2026 | | Serum Extracellular Vesicle-Associated GULP1 Is a Key Indicator of Hepatocellular Carcinoma
Oncology research, 34(2). : 13-13, 2026 | 김순선, 은정우, 정재연 |
| 2026 | | Development and Validation of a Lectin-independent Liquid Chromatography–Tandem Mass Spectrometry Method for Serum Glycosylated Alpha-fetoprotein Analysis and Comparison with a Liquid-phase Binding Assay
Annals of laboratory medicine, 46(1). : 62-71, 2026 | 김순선, 정재연 |
| 2025 | | Mechanistic loop-resolution strategies for short-type single-balloon enteroscopy-assisted ERCP in patients post Roux-en-Y hepaticojejunostomy with a preserved stomach and duodenum
Endoscopy, 57(12). : 1386-1393, 2025 | 김순선, 양민재, 유병무, 황재철 |
| 2025 | | Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression
Scientific reports, 15(1). : 42459-42459, 2025 | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2025 | | Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea
Journal of liver cancer, 25(2). : 169-177, 2025 | 김순선, 한지은 |
| 2025 | | Temporal Dynamics and Treatment Outcomes of Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Multicenter Retrospective Study from South Korea
Gut and liver, 19(6). : 868-877, 2025 | 김순선 |
| 2025 | | Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
Journal of liver cancer, 25(2). : 160-168, 2025 | 김순선, 한지은 |
| 2025 | | Role and Activities of the Ethics and Legislation Committee of the Korean Society of Gastroenterology: Introduction to Medical Appraisal and the Medical Dispute Casebook
The Korean journal of gastroenterology, 85(4). : 491-496, 2025 | 김순선 |
| 2025 | | Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study
European journal of gastroenterology & hepatology, 37(10). : 1166-1172, 2025 | 김순선 |
| 2025 | | A Novel Liver-Specific Pseudogene Biomarker, BMS1P8, for Diagnosis and Prognosis in Hepatocellular Carcinoma
Frontiers in bioscience (Landmark edition), 30(7). : 41684-41684, 2025 | 김순선, 은정우, 정재연, 한지은 |
| 2025 | | Impact of Antihypertensive and Lipid-Lowering Agents on Hepatocellular Carcinoma Risk in Patients with Fatty Liver Disease and Diabetes
Digestive diseases and sciences, 70(7). : 2475-2486, 2025 | 김순선, 정재연, 조효정 |
| 2025 | | Outcomes of Endoscopic Papillectomy After an Insulated Plastic Pancreatic Stent Placement: A Retrospective Cohort Study
Journal of gastroenterology and hepatology, 40(7). : 1703-1710, 2025 | 김순선, 양민재, 유병무, 최창영, 황재철 |
| 2025 | | GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma
Clinical and molecular hepatology, 31(3). : 914-934, 2025 | 김순선, 은정우, 임수빈, 정재연, 조효정, 한지은 |
| 2025 | | CTC-537E7.3 as a Liver-Specific Biomarker for Hepatocellular Carcinoma: Diagnostic and Prognostic Implications
Current issues in molecular biology, 47(7). : 563-563, 2025 | 김순선, 은정우, 정재연, 한지은 |
| 2025 | | Clinical Course and Prognosis of Long-Term Survivors of Hepatocellular Carcinoma
Alimentary pharmacology & therapeutics, 61(8). : 1333-1342, 2025 | 김순선 |
| 2025 | | Comment on “Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort”
JHEP reports, 7(5). : 101334-101334, 2025 | 김순선, 한지은 |
| 2025 | | KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
Clinical and molecular hepatology, 31S. : S1-S31, 2025 | 김순선 |
| 2025 | | Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Annals of hepatology, 30(1). : 101749-101749, 2025 | 김순선, 정재연 |
| 2025 | | The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on “The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study”
Clinical and molecular hepatology, 31(1). : 316-318, 2025 | 김순선, 정재연 |
| 2024 | | Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133
Cell death & disease, 15(8). : 634-634, 2024 | 김순선, 은정우, 임수빈, 정재연, 조효정, 한지은 |
| 2024 | | Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Clinical and molecular hepatology, 30(3). : 360-374, 2024 | 김순선, 은정우, 임수빈, 정재연, 조효정 |
| 2024 | | SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
Scientific reports, 14(1). : 9761-9761, 2024 | 김순선, 정재연, 조효정 |
| 2024 | | The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
Cancers, 16(2). : 249-249, 2024 | 김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2024 | | Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
Cancers, 16(1). : 150-150, 2024 | 김순선 |
| 2023 | | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea
Alimentary pharmacology & therapeutics, 58(11-12). : 1185-1193, 2023 | 김순선 |
| 2023 | | Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma
World journal of gastroenterology, 29(47). : 6122-6137, 2023 | 김순선, 노충균, 양민재, 이길호, 임선교, 정재연, 조효정, 한지은 |
| 2023 | | Drug Induced Liver Injury Prediction with Injective Molecular Transformer
BHI 2023 - IEEE-EMBS International Conference on Biomedical and Health Informatics, Proceedings, : 1-4, 2023 | 김순선, 정재연, 조효정, 한지은 |
| 2023 | | Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma
Journal of experimental & clinical cancer research : CR, 42(1). : 288-288, 2023 | 김순선, 은정우, 정재연, 조효정 |
| 2023 | | Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
Journal of liver cancer, 23(1). : 189-201, 2023 | 김순선, 한지은 |
| 2023 | | Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis
The Korean journal of gastroenterology, 82(3). : 127-136, 2023 | 김순선 |
| 2023 | | Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
Cancers, 15(16). : 4156-4156, 2023 | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2023 | | Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
Gut and liver, 17(4). : 610-619, 2023 | 김순선, 정재연, 조효정 |
| 2023 | | Consensus Definition of Blood Samples from the Subcategorized Normal Controls in the Korea Biobank Network
Journal of clinical medicine, 12(9). : 3080-3080, 2023 | 김순선, 정재연, 한지은 |
| 2023 | | Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Cancer communications (London, England), 43(4). : 455-479, 2023 | 김석휘, 김순선, 김영배, 은정우, 임수빈, 정재연, 조효정 |
| 2023 | | Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
International journal of molecular sciences, 24(5). : 4272-4272, 2023 | 김봉완, 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
European journal of gastroenterology & hepatology, 35(4). : 431-439, 2023 | 김순선 |
| 2023 | | Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Clinical and molecular hepatology, 29(1). : 120-134, 2023 | 김순선 |
| 2022 | | Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
Journal of liver cancer, 22(2). : 125-135, 2022 | 김순선, 박범희, 정재연, 조효정, 한지은 |
| 2022 | | 295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma
European journal of cancer (Oxford, England : 1990), 174(S1). : S105-S105, 2022 | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | 258 (PB038) - SORT1 with oncogenic potential associated hypomethylation and promotes tumor progression in hepatocellular carcinoma
European journal of cancer (Oxford, England : 1990), 174(S1). : S94-S94, 2022 | 김순선, 은정우, 정재연, 조효정, 한지은 |
| 2022 | | Forms of cholangitis to be considered after SARS-CoV-2 infection
Clinical and molecular hepatology, 28(4). : 929-930, 2022 | 김순선 |
